Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 1
2006 1
2009 1
2010 2
2012 1
2013 2
2014 5
2015 7
2016 6
2017 2
2018 2
2021 3
2022 2
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

37 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean jinchang cui (6 results)?
Associations of nirmatrelvir-ritonavir treatment with death and clinical improvement in hospitalized patients with COVID-19 during the Omicron wave in Beijing, China: a multicentre, retrospective cohort study.
Han X, Li C, Yuan X, Cui J, Han Z, Meng J, Zhao W, Xie F, Wang K, Liu Y, Muo G, Xi N, Zheng M, Wang R, Xiao K, Chen W, Xiong J, Zhao D, Zhang X, Han X, Cheng H, Yu Z, Shi Y, Xie W, Xie L. Han X, et al. Among authors: cui j. Ann Med. 2024 Dec;56(1):2313062. doi: 10.1080/07853890.2024.2313062. Epub 2024 Feb 14. Ann Med. 2024. PMID: 38354691 Free PMC article.
Real-world effectiveness of nirmatrelvir-ritonavir versus azvudine in hospitalized patients with COVID-19 during the omicron wave in Beijing: a multicenter retrospective cohort study.
Han X, Gao D, Li C, Yuan X, Cui J, Zhao W, Xie F, Wang K, Liu Y, Muo G, Xi N, Zheng M, Wang R, Xiao K, Zhao D, Zhang X, Han X, Wang B, Zhang T, Xie W, Xie L. Han X, et al. Among authors: cui j. BMC Infect Dis. 2024 Jan 8;24(1):57. doi: 10.1186/s12879-023-08965-8. BMC Infect Dis. 2024. PMID: 38191304 Free PMC article.
Optimal treatment of ceftazidime-avibactam and aztreonam-avibactam against bloodstream infections or lower respiratory tract infections caused by extensively drug-resistant or pan drug-resistant (XDR/PDR) Pseudomonas aeruginosa.
Kang Y, Xie L, Yang J, Cui J. Kang Y, et al. Among authors: cui j. Front Cell Infect Microbiol. 2023 Jun 28;13:1023948. doi: 10.3389/fcimb.2023.1023948. eCollection 2023. Front Cell Infect Microbiol. 2023. PMID: 37457958 Free PMC article.
Pharmacokinetic/pharmacodynamic modelling to evaluate the efficacy of various dosing regimens of ceftazidime/avibactam in patients with pneumonia caused by Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae: a multicentre study in northern China.
Kang Y, Zhou Q, Cui J. Kang Y, et al. Among authors: cui j. J Glob Antimicrob Resist. 2021 Dec;27:67-71. doi: 10.1016/j.jgar.2021.07.020. Epub 2021 Aug 21. J Glob Antimicrob Resist. 2021. PMID: 34428596 Free article.
37 results